| N-methyl N-(2-hydroxy-ethyl) arachidonoyl amine |
LMFA08020025 |
Fatty Acyls [FA] |
Fatty amides [FA08] |
N-acyl amines [FA0802] |
| N-(2-hydroxyethyl)heptadecanamide |
LMFA08040049 |
Fatty Acyls [FA] |
Fatty amides [FA08] |
N-acyl ethanolamines (endocannabinoids) [FA0804] |
| Arachidonyl lysolecithin |
LMGP01050048 |
Glycerophospholipids [GP] |
Glycerophosphocholines [GP01] |
Monoacylglycerophosphocholines [GP0105] |
| GlcNalpha1-6Ins-1-P-Cer(t18:0/26:0) |
LMSP06040001 |
Sphingolipids [SP] |
Acidic glycosphingolipids [SP06] |
Phosphoglycosphingolipids [SP0604] |
| pregnenolone |
LMST02030088 |
Sterol Lipids [ST] |
Steroids [ST02] |
C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives [ST0203] |
| Allopregnanolone |
LMST02030130 |
Sterol Lipids [ST] |
Steroids [ST02] |
C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives [ST0203] |
| (22S)-22-hydroxy-24,25,26,27-tetranorvitamin D3 / (22S)-22-hydroxy-23,24,25,26,27-pentanorcholecalci |
LMST03020016 |
Sterol Lipids [ST] |
Secosteroids [ST03] |
Vitamin D3 and derivatives [ST0302] |
|
Metabolite Feature Name
|
HMDB
|
Kegg Compund ID
|
|
|
| 2-Methylbutyrylglycine |
HMDB00339 |
|
|
|
| Cystathionine |
HMDB00099 |
C02291 |
|
|
| N-acetyl-Cysteine |
HMDB01890 |
C06809 |
|
|
